Aprea Therapeutics (APRE) Earnings (2018 - 2026)
Aprea Therapeutics (APRE) earnings from Sep 30, 2018 to Mar 31, 2026. The TTM Aprea Therapeutics (APRE) earnings is -$12M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Aprea Therapeutics (APRE) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -15.00% |
| 3 Years TTM | -52.14% |
| 5 Years TTM | -25.96% |
| All Time TTM | -3.41% |
Annual Earnings change of Aprea Therapeutics (APRE)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$3.29M | -73.89% |
| 2025 | -$13M | -2.78% |
| 2024 | -$13M | -9.31% |
| 2023 | -$14M | -87.32% |
| 2022 | -$113M | +203.42% |
| 2021 | -$37M | -30.57% |
| 2020 | -$53M | +90.59% |
| 2019 | -$28M | +80.68% |
| 2018 | -$16M | +2.24% |
| 2017 | -$15M | N/A |
Comparison Aprea Therapeutics (APRE) five years earnings CAGR with competitors
Aprea Therapeutics (APRE) five years earnings CAGR is -25.96%.